» Articles » PMID: 38861993

Modulation of FGF Pathway Signaling and Vascular Differentiation Using Designed Oligomeric Assemblies

Abstract

Many growth factors and cytokines signal by binding to the extracellular domains of their receptors and driving association and transphosphorylation of the receptor intracellular tyrosine kinase domains, initiating downstream signaling cascades. To enable systematic exploration of how receptor valency and geometry affect signaling outcomes, we designed cyclic homo-oligomers with up to 8 subunits using repeat protein building blocks that can be modularly extended. By incorporating a de novo-designed fibroblast growth factor receptor (FGFR)-binding module into these scaffolds, we generated a series of synthetic signaling ligands that exhibit potent valency- and geometry-dependent Ca release and mitogen-activated protein kinase (MAPK) pathway activation. The high specificity of the designed agonists reveals distinct roles for two FGFR splice variants in driving arterial endothelium and perivascular cell fates during early vascular development. Our designed modular assemblies should be broadly useful for unraveling the complexities of signaling in key developmental transitions and for developing future therapeutic applications.

Citing Articles

Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis.

Lin H, Wang X, Chung M, Cai S, Pan Y J Transl Med. 2025; 23(1):240.

PMID: 40016790 PMC: 11869441. DOI: 10.1186/s12967-024-06060-3.


Design of high-affinity binders to immune modulating receptors for cancer immunotherapy.

Yang W, Hicks D, Ghosh A, Schwartze T, Conventry B, Goreshnik I Nat Commun. 2025; 16(1):2001.

PMID: 40011465 PMC: 11865580. DOI: 10.1038/s41467-025-57192-z.


FGF-based drug discovery: advances and challenges.

Chen G, Chen L, Li X, Mohammadi M Nat Rev Drug Discov. 2025; .

PMID: 39875570 DOI: 10.1038/s41573-024-01125-w.


Design of pseudosymmetric protein hetero-oligomers.

Kibler R, Lee S, Kennedy M, Wicky B, Lai S, Kostelic M Nat Commun. 2024; 15(1):10684.

PMID: 39695145 PMC: 11655659. DOI: 10.1038/s41467-024-54913-8.


Engineered receptors for soluble cellular communication and disease sensing.

Piraner D, Abedi M, Duran Gonzalez M, Chazin-Gray A, Lin A, Zhu I Nature. 2024; 638(8051):805-813.

PMID: 39542025 PMC: 11839477. DOI: 10.1038/s41586-024-08366-0.


References
1.
Putnam C, Hammel M, Hura G, Tainer J . X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. Q Rev Biophys. 2007; 40(3):191-285. DOI: 10.1017/S0033583507004635. View

2.
Holzmann K, Grunt T, Heinzle C, Sampl S, Steinhoff H, Reichmann N . Alternative Splicing of Fibroblast Growth Factor Receptor IgIII Loops in Cancer. J Nucleic Acids. 2011; 2012:950508. PMC: 3238399. DOI: 10.1155/2012/950508. View

3.
Javerzat S, Auguste P, Bikfalvi A . The role of fibroblast growth factors in vascular development. Trends Mol Med. 2002; 8(10):483-9. DOI: 10.1016/s1471-4914(02)02394-8. View

4.
Gong S . Isoforms of receptors of fibroblast growth factors. J Cell Physiol. 2014; 229(12):1887-95. DOI: 10.1002/jcp.24649. View

5.
Yang C, Sesterhenn F, Bonet J, van Aalen E, Scheller L, Abriata L . Bottom-up de novo design of functional proteins with complex structural features. Nat Chem Biol. 2021; 17(4):492-500. DOI: 10.1038/s41589-020-00699-x. View